“Venlafaxine and Genetic Variation; Implications for Therapeutic Efficacy and Adverse Effects”, Mol. Med. Com., vol. 1, no. 01, pp. 79–91, Dec. 2021, doi: 10.55627/mmc.001.01.0020.